Coronavirus Disease 2019 Case Fatality and Parkinson's Disease.
作者信息
Zhang Qiang, Schultz Jordan L, Aldridge Georgina M, Simmering Jacob E, Narayanan Nandakumar S
机构信息
Department of Neurology, University of Iowa, Iowa City, Iowa, USA.
Department of Psychiatry, University of Iowa, Iowa City, Iowa, USA.
出版信息
Mov Disord. 2020 Nov;35(11):1914-1915. doi: 10.1002/mds.28325. Epub 2020 Oct 15.
Abstract
摘要
相似文献
1
Coronavirus Disease 2019 Case Fatality and Parkinson's Disease.2019冠状病毒病病死率与帕金森病
Mov Disord. 2020 Nov;35(11):1914-1915. doi: 10.1002/mds.28325. Epub 2020 Oct 15.
2
An educational case series of Parkinson's disease during the COVID-19 pandemic.2019冠状病毒病大流行期间帕金森病的教育病例系列
Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):134-136. doi: 10.1016/j.neurol.2020.07.007. Epub 2020 Sep 12.
3
Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.2020 年 2 月至 2021 年 3 月期间美国种族和农村地区与 SARS-CoV-2 感染、死亡率和病死率关联变化的研究：一项基于人群的队列研究。
PLoS Med. 2021 Oct 21;18(10):e1003807. doi: 10.1371/journal.pmed.1003807. eCollection 2021 Oct.
4
Dementia and Parkinson's Disease: Risk Factors for 30-Day Mortality in Nursing Home Residents with COVID-19.痴呆和帕金森病：COVID-19 养老院居民 30 天死亡率的危险因素。
J Alzheimers Dis. 2021;84(3):1173-1181. doi: 10.3233/JAD-210319.
5
Association of Social and Behavioral Risk Factors With Mortality Among US Veterans With COVID-19.社会行为风险因素与美国 COVID-19 退伍军人死亡率的关联。
JAMA Netw Open. 2021 Jun 1;4(6):e2113031. doi: 10.1001/jamanetworkopen.2021.13031.
6
Pseudo-likelihood based logistic regression for estimating COVID-19 infection and case fatality rates by gender, race, and age in California.基于伪似然的逻辑回归估计加利福尼亚州按性别、种族和年龄划分的 COVID-19 感染率和病死率。
Epidemics. 2020 Dec;33:100418. doi: 10.1016/j.epidem.2020.100418. Epub 2020 Nov 9.
7
Outcome of Parkinson's Disease Patients Affected by COVID-19.受新冠病毒感染的帕金森病患者的结局
Mov Disord. 2020 Jun;35(6):905-908. doi: 10.1002/mds.28104. Epub 2020 May 28.
8
Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada.欧洲、美国和加拿大的 COVID-19 年龄较大人群和特定国家的病死率。
Infection. 2021 Feb;49(1):111-116. doi: 10.1007/s15010-020-01538-w. Epub 2020 Oct 24.
9
Rapid worsening in Parkinson's disease may hide COVID-19 infection.帕金森病的快速恶化可能掩盖新冠病毒感染。
Parkinsonism Relat Disord. 2020 Jun;75:126-127. doi: 10.1016/j.parkreldis.2020.05.008. Epub 2020 May 8.
10
Impact of Coronavirus Disease 2019 Pandemic on Cognition in Parkinson's Disease.2019年冠状病毒病大流行对帕金森病认知功能的影响
Mov Disord. 2020 Oct;35(10):1717-1718. doi: 10.1002/mds.28254. Epub 2020 Sep 8.
引用本文的文献
1
COVID-19 and Parkinson's disease: a single-center study and Mendelian randomization study.2019冠状病毒病与帕金森病：一项单中心研究及孟德尔随机化研究
Sci Rep. 2024 Jul 17;14(1):16517. doi: 10.1038/s41598-024-66197-5.
2
[COVID-19: Neurological manifestations and complications during the acute phase of the disease].[新型冠状病毒肺炎：疾病急性期的神经表现及并发症]
Bull Acad Natl Med. 2023 Jun 27. doi: 10.1016/j.banm.2023.02.014.
3
Extracellular Vesicles: The Invisible Heroes and Villains of COVID-19 Central Neuropathology.细胞外囊泡：新冠病毒中枢神经病理学中无形的“英雄”与“反派”
Adv Sci (Weinh). 2024 Mar;11(10):e2305554. doi: 10.1002/advs.202305554. Epub 2023 Dec 24.
4
Does COVID-19 Trigger the Risk for the Development of Parkinson's Disease? Therapeutic Potential of Vitamin C.COVID-19 是否会引发帕金森病的风险？维生素 C 的治疗潜力。
Mol Neurobiol. 2024 Dec;61(12):9945-9960. doi: 10.1007/s12035-023-03756-3. Epub 2023 Nov 14.
5
Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.COVID-19 住院患者与帕金森病患者的临床特征和转归：一项基于英国多中心的研究。
PLoS One. 2023 Jul 31;18(7):e0285349. doi: 10.1371/journal.pone.0285349. eCollection 2023.
6
Exploration of the Shared Molecular Mechanisms between COVID-19 and Neurodegenerative Diseases through Bioinformatic Analysis.通过生物信息学分析探索 COVID-19 和神经退行性疾病之间的共享分子机制。
Int J Mol Sci. 2023 Mar 2;24(5):4839. doi: 10.3390/ijms24054839.
7
Effects and parameters of community-based exercise on motor symptoms in Parkinson's disease: a meta-analysis.基于社区的运动对帕金森病运动症状的影响及参数：荟萃分析。
BMC Neurol. 2022 Dec 29;22(1):505. doi: 10.1186/s12883-022-03027-z.
8
Older patients with COVID-19 and neuropsychiatric conditions: A study of risk factors for mortality.老年 COVID-19 患者伴神经精神疾病：一项死亡率危险因素研究。
Brain Behav. 2022 Dec;12(12):e2787. doi: 10.1002/brb3.2787. Epub 2022 Nov 10.
9
COVID-19 vaccine acceptance and hesitancy in patients with Parkinson's disease.帕金森病患者对 COVID-19 疫苗的接受度和犹豫。
Front Public Health. 2022 Oct 11;10:977940. doi: 10.3389/fpubh.2022.977940. eCollection 2022.
10
Characterization of exogenous αSN response genes and their relation to Parkinson's disease using network analyses.利用网络分析对外源性α-突触核蛋白反应基因进行表征及其与帕金森病的关系
Front Pharmacol. 2022 Sep 30;13:966760. doi: 10.3389/fphar.2022.966760. eCollection 2022.
本文引用的文献
1
Predictors of COVID-19 outcome in Parkinson's disease.帕金森病患者 COVID-19 结局的预测因素。
Parkinsonism Relat Disord. 2020 Sep;78:134-137. doi: 10.1016/j.parkreldis.2020.08.012. Epub 2020 Aug 13.
2
COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.意大利伦巴第地区帕金森病患者的 COVID-19 状况。
Mov Disord. 2020 Jul;35(7):1089-1093. doi: 10.1002/mds.28176. Epub 2020 Jun 26.
3
Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study.新冠疫情对帕金森病临床特征的影响：一项基于社区的病例对照研究。
Mov Disord. 2020 Aug;35(8):1287-1292. doi: 10.1002/mds.28170. Epub 2020 Jun 11.
4
Outcome of Parkinson's Disease Patients Affected by COVID-19.受新冠病毒感染的帕金森病患者的结局
Mov Disord. 2020 Jun;35(6):905-908. doi: 10.1002/mds.28104. Epub 2020 May 28.
5
African-American COVID-19 Mortality: A Sentinel Event.非裔美国人的新冠病毒死亡率：一个标志性事件。
J Am Coll Cardiol. 2020 Jun 2;75(21):2746-2748. doi: 10.1016/j.jacc.2020.04.040. Epub 2020 Apr 21.
6
[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].[中国2019新型冠状病毒病（COVID-19）疫情的流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.
Zotero 插件